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Pooling biomarker data across multiple studies enables researchers
to get more precise estimates of the association between biomarker ex-
posure measurements and disease risks due to increased sample sizes.
However, biomarker measurements vary significantly across different
assays and laboratories, and therefore calibration of the local lab-
oratory measurements to a reference laboratory is necessary before
pooling data. We propose two methods that can estimate a nonlin-
ear relationship between biomarker exposure measurements and dis-
ease risks using spline functions with a nested case-control study de-
sign: full calibration and internalized calibration. The full calibration
method calibrates all observations using a study-specific calibration
model while the internalized calibration method only calibrates ob-
servations that do not have reference laboratory measurements avail-
able. We compare the two methods with a naive method whereby
data are pooled without calibration. We find that: (1) Internalized
and full calibration methods have substantially better performance
than the naive method in terms of average relative bias and coverage
rate. (2) Full calibration is more robust than internalized calibration
when the size of calibration subsets varies. We apply our methods
to a pooling project with nested case-control study design to esti-
mate the association of circulating Vitamin D levels with the risk of
colorectal cancer.
1. Introduction. It is common to combine biomarker data across dif-
ferent studies to evaluate the association between biomarker exposures and
disease risks. The attraction of pooling data for statistical analysis is that the
increased sample size from pooling enables us to get more precise estimates
of the association between biomarker measurements and disease risks, facili-
tating subgroup analysis, for example [Key et al. (2010); Smith-Warner et al.
(2006); Tworoger et al. (2006)]. Studies that pooled data together to examine
biomarker-disease associations include: Circulating Vitamin D and Colorec-
tal Cancer [McCullough et al. (2018)], Circulating 25-Hydroxyvitamin D and
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the Risk of Rarer Cancers [Gallicchio et al. (2010)], The Endogenous Hor-
mones, Nutritional Biomarkers and Prostate Cancer Collaborative Group
[Crowe et al. (2014); Key et al. (2015)] and the NCI Breast and Prostate
Cancer Cohort Consortium [Tsilidis et al. (2013)].
We need to account for potential between-study variation of biomarker
measurements stemming from assay or laboratory differences before pool-
ing biomarker data. For instance, the variation of measurements of serum
25-hydroxyvitamin D (25(OH)D) concentration can reach up to 40% across
different assays, laboratories and even seasons of a year [Barake et al. (2012);
Lai et al. (2012); Snellman et al. (2010)]. Also, hormones such as estradiol
and testosterone have high variation across assays and laboratories [Key et
al. (2010); Smith-Warner et al. (2006); Tworoger et al. (2006)]. Therefore,
additional steps are needed to standardize biomarker measurements across
different laboratories before data analysis. We employ a study-specific cali-
bration model for each study to transform the original data into comparable
measurements. The calibration is performed by first selecting a reference
laboratory, to which a subset of biospecimens from each study are sent for
re-assaying. We can therefore estimate a calibration model for each study
based on the local and corresponding reference laboratory measurements
among the subset of biospecimens selected for re-assaying. The models are
then used to impute the reference laboratory measurements for the remain-
ing observations with only local laboratory measurements available. Due to
their rarity, cases are not usually used for assay calibration. Instead, con-
trols are usually chosen for re-assaying in a reference laboratory [Sloan et
al. (2019)].
The calibration approach can also be regarded as a covariate measurement
error problem. Instead of observing the true covariate measurement X for
each subject, we only have surrogate measurement W available[Carroll et
al. (2006)]. The study-specifc calibration model is therefore trying to correct
for the measurement errors. In our paper, we build our method based on
the regression calibration approach which is widely used for correcting for
measurement error-caused biases[Carroll et al. (2006); Rosner et al. (1990)].
Sloan and Wang (2019) proposed methods for pooling biomarker data
from nested case-control studies. However, their method assumes that bioma-
rker measurements have a linear relationship with log relative risk(RR) of
diseases where a nonlinear dose-response relationship of biomarker mea-
surements and disease risk is often observed in practice. For example, a
nonlinear inverse association between 25(OH)D and breast cancer risk was
observed among postmenopausal women [Bauer et al. (2013)]; similarly, a
nonlinear relationship between 25(OH)D and indices of arterial stiffness and
SPLINE ANALYSIS OF BIOMARKER DATA. . . 3
arteriosclerosis was found in an elderly population in the Netherlands [van
Dijk et al. (2014)]. Thus, restricting the biomaker-disease relationship to be
linear may lead to biased estimates when the true association is nonlinear.
In this paper, we extend the method for pooling nested case-control stud-
ies to allow for a nonlinear relationship between biomarker effects and dis-
ease risks using spline functions [Durrleman et al. (1989)]. We first calibrate
biomarker measurements across multiple studies using the Internalized and
Full calibration methods [Sloan et al. (2019)]. We then obtain estimates for
the coefficients of the spline functions based on an approximate likelihood
function. However, the variances of the estimates are not directly obtain-
able due to the uncertainty in the estimation of calibration parameters, and
therefore we use empirical sandwich variance estimates.
In Section 2, we present the models and statistical methods. In Section 3,
we evaluate the performance of our methods in simulation studies. In Section
4, we apply the methods to a pooling project investigating the relationship
between circulating Vitamin D levels with colorectal cancer, and we present
a discussion in Section 5.
2. Methods.
2.1. Model and approximate conditional likelihood. Let 1, . . . , S index
the studies that contributed to the pooling project, where the first Q stud-
ies use local laboratories for measurement of biomarkers. We use nsj and
msj to denote the number of cases and controls, respectively in the j
th stra-
tum of the sth study. Within each stratum, we use i to index individuals,
where controls correspond to i = 1, 2, . . . ,msj , and the cases correspond to
i = msj + 1,msj + 2, . . . ,msj + nsj .
Let Ysji denote the binary disease status of each individual, Xsji be the
biomarker measurements taken from the reference laboratory, Wsji be the
biomarker measurements taken from local laboratories, and let Zsji be a
vector of potential confounders. For each study using a local laboratory, a
subset of samples were sent to the reference laboratory for re-assaying to
obtain reference biomarker measurements Xsji, and we refer this subset as
the calibration subset. Therefore, for studies that use local laboratories for
biomarker measurements, Xsji are available only in the calibration subsets,
and Wsji are available for all individuals. Since the local measurements can
vary systematically across different studies, using Wsji instead of Xsji can
lead to significantly biased estimates of the biomarker-disease relationship.
We propose to calibrate the local laboratory measurements by building cal-
ibration models based on the calibraton subsets in each local laboratory.
To model the possibly nonlinear relationship between the biomarker and
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the disease risk, we use spline functions [Durrleman et al. (1989)]. Let s
index a study and j a stratum within a study. The logistic regression model
with spline functions can be written as
logit(P (Ysji = 1|Xsji,Zsji)) = β0sj + βTXf(Xsji) + βTZZsji ,
where β0sj is the study and stratum-specific intercept, and f(Xsji) is a
K × 1 column vector of spline basis functions at Xsji, K depends on the
type of spline functions and the number of knots selected, Zsji is a P × 1
column vector of potential confounders, and βX and βZ are column vectors
of the corresponding regression coefficients. Note that in nested case-control
studies with density sampling [Breslow et al. (1978)] βTX
[
f(Xsji)− f(Xsji′)
]
represents the log relative risk(RR) associated with two distinct biomarker
measurements Xsji and Xsji′ in the same stratum. We focus on point and
interval estimates of βX in this paper.
Let vectors Xsj , W sj and matrix Zsj contains the corresponding mea-
surements of individuals from the jth stratum of the sth study. The condi-
tional likelihood function is [Breslow et al. (1978)]:
L =
∏
s
∏
j
P (Ysj1 = 0, . . . , Ysjmsj = 0, Ysj(msj+1)
= 1, . . . , Ysj(msj+nsj)
= 1|Xsj ,Zsj ,
msj+nsj∑
i=1
Ysji = nsj)
=
∏
s
∏
j
∏nsj
l=1
exp
(
β0sj + β
T
Xf(Xsj(msj+l)
) + βTZZsj(msj+l)
)∑
(i1,...,insj
)∈A
∏nsj
l=1
exp(β0sj + β
T
X
f(Xsjil
) + βT
Z
Zsjil
)
=
∏
s
∏
j
1 + ∑
(i1,...,insj
)∈A′
exp
(
β
T
X
nsj∑
l=1
[
f(Xsjil
)− f(Xsj(msj+l))
]
+ β
T
Z
nsj∑
l=1
[
Zsjil
− Zsj(msj+l)
])−1 ,
where A is the set of all subsets of indices of size nsj of the set {1, 2, . . . ,msj ,
msj + 1, . . . ,msj +nsj} and (i1, i2, . . . , insj ) corresponds to one specific such
subset of size nsj . A
′ is the subset of A that excludes subset where i1 =
msj + 1, i2 = msj + 2, . . . , insj = msj + nsj .
The conditional likelihood function cannot be calculated directly since
Xsj is not available for all individuals if the biomarker measurements were
taken only in a local laboratory. To derive an approximate conditional like-
lihood under the nested case-control study design, we make the ‘surrogacy’
assumption that takes account of the study design:
f(Ysj |Xsj ,Wsj ,Zsj ,
nsj+msj∑
i=1
Ysji = nsj) = f(Y sj |Xsj ,Zsj ,
nsj+msj∑
i=1
Ysji = nsj)
which states that the outcome is conditionally independent of Wsj given
the reference laboratory measurements, other covariates of interest and the
design schema.
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Under this surrogacy assumption, the likelihood contributed from a stra-
tum using local laboratory biomarker measurements is:
Lsj =P
(
Ysji = 0, . . . , Ysjmsj = 0, Ysj(msj+1)
= 1, . . . , Ysj(msj+nsj)
= 1|W sj ,Zsj ,
msj+nsj∑
i=1
Ysji = nsj
)
=
∫
P
(
Ysji = 0, . . . , Ysjmsj = 0, Ysj(msj+1)
= 1, . . . , Ysj(msj+nsj)
= 1|Xsj ,W sj ,Zsj ,
msj+nsj∑
i=1
Ysji = nsj
)
× P
(
Xsj |W sj ,Zsj ,
msj+nsj∑
i=1
Ysji = nsj
)
dXsj
=
∫ 1 + ∑
(i1,...,insj
)∈A′
exp
(
β
T
X
nsj∑
l=1
[
f(Xsjil
)− f(Xsj(msj+l))
]
+ β
T
Z
nsj∑
l=1
[
Zsjil
− Zsj(msj+l)
])−1
× P
(
Xsj |W sj ,Zsj ,
msj+nsj∑
i=1
Ysji = nsj
)
dXsj
=E
Xsj |W sj,Zsj,
∑nsj+msj
i=1
Ysji=nsj
((
1 +
∑
(i1,...,insj
)∈A′
exp
(
β
T
X
nsj∑
l=1
[
f(Xsjil
)− f(Xsj(msj+l))
]
+ β
T
Z
nsj∑
l=1
[
Zsjil
− Zsj(msj+l)
]))−1)
where the surrogacy assumption justifies the third equation.
Let F =
(
1 +
∑
(i1,...,insj
)∈A′ exp
(
βTX
∑nsj
l=1
[
f(Xsjil
)− f(Xsj(msj+l))
]
+ βTZ
∑nsj
l=1
[
Zsjil
− Zsj(msj+l)
]))−1
.
We expand F in Taylor series around X˜sj = E
(
Xsj |W sj ,Zsj ,∑msj+nsji=1 Ysji = nsj),
yielding the following approximate likelihood contribution from the jth stra-
tum of the sth study:
L˜sj =
1 + ∑
(i1,...,insj )∈A′
exp
(
βTX
nsj∑
l=1
[
f(X˜sjil )− f(X˜sj(msj+l))
]
+ βTZ
nsj∑
l=1
[
Zsjil − Zsj(msj+l)
])−1
The approximation performs best when the conditional variance and covari-
ance of Xsj are small or the biomarker effect is not strong. Section 1 of
Supplementary Materials provides a detailed derivation of the approximate
conditional likelihood and the conditions when the approximation works
well. To get an estimate of X˜sji, we propose the calibration model in the
next section.
2.2. Calibration model. In each study that uses local laboratories, the
study-specific calibration models can be developed by utilizing the subset of
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controls selected for re-assaying in the reference laboratory which therefore
have biomarker measurements from both local and reference laboratories.
The calibration models can thus be used to impute the reference biomarker
measurements for the remaining subjects that only have local laboratory
measurements.
We make the calibration assumption that the calibration model will not
be heavily affected by other covariates apart from the local laboratory mea-
surement for the same participant; that is,
E
(
Xsji|W sj ,Zsj ,
msj+nsj∑
i=1
Ysji = nsj
)
≈ E
(
Xsji|Wsji,
msj+nsj∑
i=1
Ysji = nsj
)
We assume a linear relationship between reference laboratory measurements
and local laboratory measurements for calibration.
(2.1) E
Xsji|Wsji,msj+nsj∑
i=1
Ysji = nsj
 = as + bsWsji,
where as, bs are study-specific calibration model coefficients. Notice that the
calibration parameters are the same across different strata in each study.
However, we can relax this constraint by assuming the calibration models
also depend on matching factors: E
(
Xsji|Wsji,M sji,∑msj+nsji=1 Ysji = nsj) =
as + bsWsji + c
T
sM sji, where M sji are the matching factors that may have
an effect on the calibration models. Sloan et al. (2019) suggested that the
equation 2.1 is sufficient in most study settings. In 2.1, although a linear
term of Wsji is typically sufficient to model the Xsji − Wsji relationship,
nonlinear terms in Wsji can also be included if appropriate.
The calibration models are usually fitted among controls because case
bio-specimens are often not available, and therefore the calibration model
used in practice is:
E (Xsji|Wsji, Ysji = 0) = as,co + bs,coWsji
where we use as,co, bs,co to denote the calibration models fitted among con-
trols only. âs,co, b̂s,co are generally not consistent estimates of as, bs. Sloan
and Wang (2019) gave conditions for as,co ≈ as, bs,co ≈ bs under bivari-
ate normality of Xsj and W sj in a 1:1 nested case-control study. It is
straightforward to generalize their results to nsj : msj matching. This yields
bs,co ≈ bs when V ar(Xsj |∑msj+nsji=1 Ysji = nsj) ≈ V ar(Xsj |Y sj = 0),
and aco ≈ as when V ar(Xsj |∑msj+nsji=1 Ysji = nsj) ≈ V ar(Xsj |Y sj = 0)
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and E(Xsj |∑msj+nsji=1 Ysji = nsj) ≈ E(Xsj |Y sj = 0). In addition, if the
biomarker effect is small(i.e. βX ≈ 0), âs,co, b̂s,co will also be close to as, bs.
Define X˜sji as the ‘reference’ biomarker measurement as an alternative to
Xsji for use in the pooled analysis. If the study already used the reference
laboratory for measurement of all participants, no calibration is needed and
X˜sji = Xsji. For studies that used local laboratory for measurement, we
define the full calibration and internalized calibration methods [Sloan et al.
(2019)] as follows:
Full Calibration : X˜sji = Ê(Xsji|Wsji, Ysji = 0)
Internalized Calibration :
X˜sji =

Xsji, if reference lab
measurement available
Ê(Xsji|Wsji, Ysji = 0), otherwise.
Therefore, for studies using local laboratories for biomarker measure-
ment, all participants’ biomarker measurements are calibrated under the
full calibration method while under the internalized calibration method, the
biomarker measurements are calibrated for participants who only have the
local laboratory measurements available.
2.3. Parameter Estimation. We define a = [a1, a2, . . . , aQ], b = [b1, b2, . . . , bQ],
and the dose-response parameters β = [βX ,βZ ]. The collective set of pa-
rameters to be estimated is therefore θ = [a, b,β]. The corresponding es-
timating equations are
[
ψa,ψb,ψβX ,ψβZ
]
= 0, where ψa,ψb,ψβX ,ψβZ
are the estimating functions for their corresponding parameters. Section 2
in the supplementary material contains the mathematical details.
We propose to obtain the point estimate for β with a two-step pseudo
maximum likelihood method [Gong et al. (1981)]. In the first step, estimates
of a, b of the calibration models are obtained by fitting linear regressions on
the subset of controls chosen for re-assaying in the reference labs, and in the
second step, β are obtained using pseudo-maximum conditional likelihood
method by solving the estimating equations
[
ψβX (â, b̂),ψβZ (â, b̂)
]
= 0,
where a, b are replaced by their estimates in the previous step.
We use a sandwich variance formula over all the estimating equations
to estimate V ar(β̂X). Therefore, V̂ ar(β̂X) can be found by collecting the
corresponding diagonal element of the sandwich variance matrix. Section 3
of the supplementary materials contains mathematical details.
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3. Simulations. We performed simulations for a 1:1 matched case-
control study design. Define sji as the error term in the linear model
of Xsji on Wsji. We assume a similar multivariate normal distribution of
Xsji,Wsji, sji as Sloan and Wang (2019) such that XsjiWsji
sji
 ∼ MVN
 µx(µx − as)/bs
0
 ,
 σ2x bsσ2ws σ2x − b2sσ2wsbsσ2ws σ2ws 0
σ2x − b2sσ2ws 0 σ2x − b2sσ2ws

This distribution yields the calibration model E(Xsji|Wsji) = as+ bsWsji
and Cov(Wsji, sji) = 0. The data were generated for each stratum of each
study first, and then a case and control were randomly chosen in each stra-
tum. In the simulation, we set µx = 0, σ
2
x = 1. We assumed four studies in
the pooled analysis with 500 case-control pairs(i.e. 1000 total subjects) in
each study, and the calibration parameters were set to be: a = [−3, 1,−1, 3],
and b = [0.5, 0.75, 1.25, 1.5]. We set Var(Wsji) = σ
2
ws = [3.8, 1.7, 0.6, 0.4] to
ensure a wide range of variation of local laboratory measurements. The
stratum specific intercept was assumed to follow a normal distribution with
mean 0 and variance 0.01: β0sj ∼ N(0, 0.01).
The spline functions were chosen to be restricted cubic splines with three
knots fixed at the (25th, 50th, 75th) quantile of N(0, 1). We assume a simple
risk model without additional covariates:
logit (Ysji = 1|Xsji) = β0sj + βX1f1(Xsji) + βX2f2(Xsji),
where f1(Xsji) = Xsji, and f2(Xsji) = (Xsji − t1)3+ − (Xsji − t2)3+ t3−t1t3−t2 +
(Xsji− t3)3+ t2−t1t3−t2 , and t1, t2, t3 are the three knots mentioned above [Durrle-
man et al. (1989)]. Note that βX2 = 0 implies a linear relationship between
X and Y .
The simulations were performed 1000 times for different combinations
of (βX1 , βX2) and calibration proportions at 5%, 15%, and 30%, which is
defined as the proportion of controls in each study that are sent for re-
assaying in the reference laboratory.
We compare the performance of both the Internalized(IN) and Full(FC)
calibration methods in terms of average relative bias((β̂ − β)/β) over the
simulation replicates and coverage rate, which is defined as the proportion
of the estimated 95% confidence intervals containing the true value. We
also included the Naive(N) method for comparison, where no calibration is
performed and the conditional logistic regression is fitted using the local
laboratory measurements directly.
The simulation results in Tables 1 and 2 of the main paper are for a
biomarker that has an inverse effect on the diesease risk and Supplementary
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tables 1 and 2 in supplementary materials are for a biomarker that has
a positive association with the disease risk. The Naive method performs
poorly in all scenarios regardless of the calibration proportions. The average
relative bias of the naive estimates are typically larger than 0.3, and the
coverage rates are typically below 70%. The Internalized and Full calibration
estimates have consistently better performance than the Naive method. Full
calibration estimates are robust over many combinations of coefficients and
calibration proportions, where the average relative bias is typically below
0.10 when calibration proportion is 5% and below 0.05 when calibration
proportion is 15% and 30%. The coverage rates range from 93% to 97%
which are close to 95% nominal level. The internalized calibration estimates
are less robust than full calibration estimates, which tend to be more biased
when the calibration proportion is large. Section 4 of the supplementary
materials contains a mathematical justification for the relative performance
of the internalized and full calibration models.
We also plotted the curves reflecting the biomarker-disease association.
The x-axis represents the biomarker values, and the y-axis is the log RR.
Figure 1 is for the scenario where βX1 = − log(1.5) ≈ −0.41, βX2 = 0.14,
and the calibration proportions were set to be 5% and 30% respectively.
We can see that the curve estimated using naive method deviates from the
true curve substantially, while the curves estimated using the internalized
and full calibration methods are closer to the true curve. As the calibration
proportion increases, the curve estimated using the full calibration method
is closer to the true curve than the internalized calibration method. Sup-
plementary figure 1 in the supplementary materials describes the scenario
when βX1 = log(1.75) ≈ 0.56, βX2 = −0.16, and the calibration proportion
were also set to be 5%, 30% respectively. We can see similar behaviors of
the three estimated curves, where the full calibration method led to the esti-
mated curve that is closest to the true curve and is robust over all calibration
proportions.
In addition, we changed σ2ws in the simulation setup to vary the ratio of
σ2ws
σ2X
. This ratio for each study was chosen from 0.75, 0.85, 0.90, and 0.95.
The simulation results in table 3 show that the performance of calibration
models improves as this variance ratio increases, that is when the error term
in the calibration model X|W becomes smaller. The full calibration method
is more robust than the internalized method with smaller relative bias and
coverage rate closer to the 95% nominal level for all the variance ratios
considered.
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4. Applied Example. To illustrate, we applied our methods to eval-
uate the association of circulating Vitamin D level (25(OH)D) with col-
orectal cancer incidence. We based the example on two large cohort studies
in the United States: Nurses’ Health Study (NHS) [Colditz et al. (1997)]
and Health Professionals Follow-up Study (HPFS) [Choi et al. (2005)]. In
NHS, 121,701 female nurses aged 30 to 55 in 1976 were enrolled while the
HPFS had an enrollment of 51,529 male health professionals aged 40 to 75 in
1986. A subset of participants were selected from 1989 to 1995 to obtain the
measurements of their biomarkers including 25(OH)D for both studies. In-
dividuals without colorectal cancer outcome or 25(OH)D measurement were
excluded from the pooling analysis. In all, our pooling analysis consisted
of 1,876 subjects. Twenty-nine controls in each nested case-control study
were selected to have their blood samples re-assayed at Heartland Assays,
LLC(Ames, IA), the reference laboratory, during 2011-2013 [McCullough et
al. (2018)].
Table 4 presents sample sizes of the main studies and parameter esti-
mates along with standard errors of the study-specific calibration models.
The potential confounders adjusted for in the conditional logistic regres-
sion model included smoking(yes/no), BMI(greater or less than 25), physi-
cal activity(continuous) and family history of myocardial infarction(yes/no).
We chose a restricted cubic spline with three knots at the 25%, 50% and
75% quantiles of reference 25(OH)D measurements to estimate how log RR
representing the Vitamin D-colorectal cancer relationship changes with the
Vitamin D level. Table 5 presents the coefficient estimates along with cor-
responding 95% confidence intervals.
As shown in Table 5, we obtained similar point and confidence interval
estimates of coefficients from the internalized and full calibration methods.
We observed a significant linear relationship between 25(OH)D measure-
ments with log RR of colorectal cancer(p-value = 0.0211 and 0.0217, for the
internalized and full calibration methods respectively), while the nonlinear
relationship between 25(OH)D measurements with log RR of colorectal can-
cer was not significant(p-value = 0.2162 and 0.2219, for the internalized and
full calibration methods respectively). Therefore we concluded that circulat-
ing Vitamin D level has a significant linear association the log relative risk
of colorectal cancer.
After dropping the nonlinear term from the logistic regression model, in
Table 5, the point estimate of biomarker effect on the log RR of coleractal
cancer was −0.0059(RR = 0.9941), and the 95% confidence interval was
(−0.0108,−0.0010) with a p-value of 0.0177, suggesting a significant negative
linear relationship between levels of circulating 25(OH)D measurements and
SPLINE ANALYSIS OF BIOMARKER DATA. . . 11
log RR of colorectal cancer.
In figure 2, we plotted the log RR of colorectal cancer on circulating
25(OH)D measurements under both models with and without the nonlinear
spline term. We set the reference level to be individuals with minimum
25(OH)D measurement 9.734 nmol/L in the aggregated study.
5. Discussion. In this paper, we proposed statistical methods for ana-
lyzing pooled nested case-control studies. Our model can estimate a possible
nonlinear spline dose-response curve between biomarker measurements and
the diseases, which can help evaluate whether the relationship is linear or
not. We follow the common practice for study-specific calibration models in
which only controls are selected for re-assaying in the reference laboratory.
We derived an analytic expression for the variance-covariance matrix of the
estimated coefficients in the conditional logistic regression model that takes
into account of the uncertainty from fitting the calibration model.
Several remarks and recommendations can be drawn from our work. The
full calibration method is preferred compared with the internalized calibra-
tion method and naive pooling of the uncalibrated data. The full calibration
method has very small average relative bias in all simulation scenarios, and
has coverage rate close to 95% nominal level. As the calibration proportion
increases, the internalized calibration method becomes more biased than
the full calibration method. Since the calibration model is fitted on con-
trols only, estimates of the model parameters are slightly biased. The bias
in the intercept is cancelled out in the approximate likelihood function for
full calibration, but not with internalized calibration.
R code for pooling nested case-control study using restricted spline func-
tions is available at https://www.hsph.harvard.edu/molin-wang/software.
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SUPPLEMENTARY MATERIAL
Supplement A: Appendix and supplementary figures and tables
(http://www.e-publications.org/ims/support/dowload/imsart-ims.zip). Sup-
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plementary material is available online. Section 1 derives the approxiamte
likelihood; Section 2 gives the estimating equations for parameters under
control-only calibration study; Section 3 derives the sandwich variance es-
timator for the parameters; Section 4 gives a mathematical justification for
the relative performance of full and internalized calibration model; Section
5 includes addtional figures and tables.
Supplement B: R code
(http://www.e-publications.org/ims/support/dowload/imsart-ims.zip). R func-
tions for implementing the proposed methods
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Table 4
Number of cases and controls, size of the calibration study(ncal), and the estimated
intercept and slope of the calibration model for each study in the pooled analysis.
Calibration Model
Study Cases/Controls ncal â (SE) b̂ (SE)
NHS 348/694 29 -3.56(2.72) 1.13(0.97)
HPFS 267/519 29 3.38(2.95) 0.05(0.04)
Table 5
Point estimates and 95% confidence intervals for the nonlinear(and linear) association of
circulating 25(OH)D and colorectal cancer after adjusting for BMI(overweight or not),
physical activity(continuous), smoking(never/ever),Family history of colorectal
cancer(yes/no).
Method βX1 βX2
Internalized calibration -0.0116 (-0.0214, -0.0017) 7.9307e-06 (-4.6375e-06, 2.0499e-05)
Full calibration -0.0115 (-0.0213, -0.0017) 7.9885e-06 (-4.8290e-06, 2.0806e-05)
Linear model -0.0059 (-0.0108, -0.0010) -
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Fig 1: The curve reflecting the association of biomarker measurements on
disease risk, where the x-axis is the biomarker measurement and y-axis is
the log RR of the disease. The solid line is the true curve, and the dotted
and dashed lines were estimated using internalized(IN) and full calibration
methods(FC) respectively, while the dashed-dotted line is estimated using
the naive method(N). The calibration proportion is 5%(left) and 30%(right),
and the coeffcients of the spline functions are set to be −log(1.5) ≈ −0.41
and 0.14, respectively.
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Fig 2: Log colorectal cancer RR for levels of circulating 25(OH)D compared
to the reference level, 9.734 nmol/L based on the full calibration method.
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